Lowenstein Sandler represented Coya Therapeutics in the transaction.Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced the sale of $26.5 million worth of stock in a private…
Coya Therapeutics’ $26.5 Million Private Placement

























